These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8591936)

  • 1. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.
    Joly-Guillou ML; Decré D; Herrman JL; Bourdelier E; Bergogne-Bérézin E
    J Antimicrob Chemother; 1995 Oct; 36(4):619-29. PubMed ID: 8591936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
    Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].
    López-Hernández S; Alarcón T; Delgado T; de Las Cuevas MC; López-Brea M
    Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro bactericidal effect of a beta-lactam+aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Roussel-Delvallez M; Wallet F; Delpierre F; Courcol RJ
    J Chemother; 1996 Oct; 8(5):365-8. PubMed ID: 8957716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
    Visalli MA; Jacobs MR; Moore TD; Renzi FA; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Apr; 41(4):767-70. PubMed ID: 9087486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model.
    Wolff M; Joly-Guillou ML; Farinotti R; Carbon C
    Antimicrob Agents Chemother; 1999 Jun; 43(6):1406-11. PubMed ID: 10348761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.
    Hoellman DB; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Apr; 42(4):857-61. PubMed ID: 9559796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii.
    Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of various beta-lactams and beta-lactam/beta-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains.
    Brauers J; Frank U; Kresken M; Rodloff AC; Seifert H
    Clin Microbiol Infect; 2005 Jan; 11(1):24-30. PubMed ID: 15649300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Suh B; Shapiro T; Jones R; Satishchandran V; Truant AL
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):111-4. PubMed ID: 7628190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.
    Muñoz Bellido JL; Muñoz Criado S; García García I; Alonso Manzanares MA; Gutiérrez Zufiaurre MN; García-Rodríguez JA
    Antimicrob Agents Chemother; 1997 Dec; 41(12):2612-5. PubMed ID: 9420028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK; Ying CM; Lee CC; Liu ZK
    Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal effect of beta-lactams and amikacin alone or in association against Klebsiella pneumoniae producing extended spectrum beta-lactamase.
    Roussel-Delvallez M; Sirot D; Berrouane Y; Goffart M; Gourde B; Wallet F; Courcol RJ
    J Antimicrob Chemother; 1995 Jul; 36(1):241-6. PubMed ID: 8537274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles.
    Aubert G; Guichard D; Vedel G
    J Antimicrob Chemother; 1996 Jan; 37(1):155-60. PubMed ID: 8647758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.